Simplex Trading
TAK icon

Simplex Trading’s Takeda Pharmaceutical TAK Stock Holding History

Simplex Trading’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.2K Buy
+2,600
New +$45.6K ﹤0.01% 5923
2025
Q3 		– Sell
-100
Closed -$1K – 10051
2025
Q2 		$1K Sell
100
-800
-89% -$11.8K ﹤0.01% 8437
2025
Q1 		$13K Buy
900
+600
+200% +$8.41K ﹤0.01% 6937
2024
Q4 		$3K Hold
300
– – ﹤0.01% 7931
2024
Q3 		$4K Buy
300
+100
+50% +$1.42K ﹤0.01% 7775
2024
Q2 		$2K Sell
200
-800
-80% -$10.6K ﹤0.01% 8355
2024
Q1 		$13K Hold
1,000
– – ﹤0.01% 7438
2023
Q4 		$14K Buy
+1,000
New +$14.2K ﹤0.01% 7207
2023
Q3 		– Sell
-3,700
Closed -$58K – 9792
2023
Q2 		$58K Sell
3,700
-5,200
-58% -$85.2K ﹤0.01% 5701
2023
Q1 		$146K Buy
8,900
+6,800
+324% +$108K ﹤0.01% 4705
2022
Q4 		$32K Sell
2,100
-3,300
-61% -$46.1K ﹤0.01% 6395
2022
Q3 		$70K Buy
5,400
+4,700
+671% +$65.4K ﹤0.01% 5996
2022
Q2 		$9K Sell
700
-6,700
-91% -$95.6K ﹤0.01% 8395
2022
Q1 		$105K Sell
7,400
-5,000
-40% -$73.4K ﹤0.01% 6067
2021
Q4 		$169K Sell
12,400
-26,000
-68% -$365K ﹤0.01% 5429
2021
Q3 		$648K Hold
38,400
– – ﹤0.01% 3711
2021
Q2 		$646K Buy
38,400
+37,380
+3,665% +$636K ﹤0.01% 3763
2021
Q1 		$1.86M Buy
1,020
+745
+271% +$13.4K ﹤0.01% 1684
2020
Q4 		$500K Sell
275
-38
-12% -$667 ﹤0.01% 3428
2020
Q3 		$558K Sell
313
-6
-2% -$109 ﹤0.01% 2854
2020
Q2 		$571K Buy
319
+10
+3% +$180 ﹤0.01% 2749
2020
Q1 		$468K Buy
+309
New +$5.6K ﹤0.01% 2665

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Simplex Trading's TAK Position: Q1 2026 in Review

Simplex Trading opened a new position in Takeda Pharmaceutical (TAK) in Q1 2026: 5,146 shares worth $95.3K. The stake represents ﹤0.01% of the portfolio and ranks #5139 among its holdings. This is a return to the name: Simplex Trading previously reported a position in TAK as recently as Q3 2021.

Simplex Trading first reported a position in TAK in Q3 2019 and has held it in 9 quarters since. The position peaked at $535K in Q2 2021. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • Simplex Trading held 5,146 shares of Takeda Pharmaceutical worth $95.3K as of Q1 2026.
  • Takeda Pharmaceutical was a new Simplex Trading position in Q1 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5139 holding.
  • Simplex Trading first reported a position in Takeda Pharmaceutical in Q3 2019 and has held it in 9 quarters since.
  • Simplex Trading's Takeda Pharmaceutical position peaked at $535K in Q2 2021.
  • 358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.